- Home
- LANV vs SGMO Comparison
LANV vs SGMO Comparison
Compare LANV & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LANV
- SGMO
- Stock Information
- Founded
- LANV 2015
- SGMO 1995
- Country
- LANV China
- SGMO United States
- Employees
- LANV N/A
- SGMO N/A
- Industry
- LANV Blank Checks
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LANV Finance
- SGMO Health Care
- Exchange
- LANV Nasdaq
- SGMO Nasdaq
- Market Cap
- LANV 196.8M
- SGMO 180.5M
- IPO Year
- LANV N/A
- SGMO 2000
- Fundamental
- Price
- LANV $1.53
- SGMO $2.44
- Analyst Decision
- LANV
- SGMO Buy
- Analyst Count
- LANV 0
- SGMO 3
- Target Price
- LANV N/A
- SGMO $6.00
- AVG Volume (30 Days)
- LANV 9.4K
- SGMO 15.1M
- Earning Date
- LANV 08-26-2024
- SGMO 11-12-2024
- Dividend Yield
- LANV N/A
- SGMO N/A
- EPS Growth
- LANV N/A
- SGMO N/A
- EPS
- LANV N/A
- SGMO N/A
- Revenue
- LANV $409,961,427.00
- SGMO $52,291,000.00
- Revenue This Year
- LANV N/A
- SGMO N/A
- Revenue Next Year
- LANV $11.31
- SGMO $71.79
- P/E Ratio
- LANV N/A
- SGMO N/A
- Revenue Growth
- LANV N/A
- SGMO N/A
- 52 Week Low
- LANV $0.91
- SGMO $0.30
- 52 Week High
- LANV $4.28
- SGMO $3.18
- Technical
- Relative Strength Index (RSI)
- LANV 44.85
- SGMO 65.05
- Support Level
- LANV $1.34
- SGMO $1.72
- Resistance Level
- LANV $1.70
- SGMO $3.18
- Average True Range (ATR)
- LANV 0.14
- SGMO 0.42
- MACD
- LANV -0.02
- SGMO 0.06
- Stochastic Oscillator
- LANV 30.23
- SGMO 60.43
About LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.